CIPO Patents = 1

EPO Patents = 1

Trademarks = 3

Forward Citations = 49

Loading Chart...

3 inventors (with patents filed for the assignee):

William A Carter (9 out of 22 patents)

David Strayer (6 out of 6 patents)

Leo Einck (1 out of 7 patents)

10 patents: Sort by Forward Citations

1. 9315538 - Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity (2016-04-19),

2. 8722874 - Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity (2014-05-13),

3. 8075878 - Broad spectrum immune and antiviral gene modulation by oral interferon (2011-12-13),

4. 8075877 - Broad spectrum immune and antiviral gene modulation by oral interferon (2011-12-13),

5. 7943147 - dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants (2011-05-17),

6. 7678774 - Treating severe acute respiratory syndrome (2010-03-16),

7. 5958718 - Diagnosis and treatment of neuro-cognitive disorders associated with (1999-09-28),

8. 5763417 - Protection from septic shock subsequent to injury by dsRNAs (1998-06-09),

9. 5683986 - Elaboration of host defense mediators into biological fluids by systemic (1997-11-04),

10. 5593973 - Treatment of viral hepatitis with mismatched dsRNA (1997-01-14),

Hemispherx Biopharma is a biopharmaceutical company focused on the development of new immunotherapies for the treatment of chronic diseases and viral infections. Their flagship product is Ampligen, a drug candidate for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, influenza, and other infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

10 Patents

#93 in Philadelphia, PA

#1,062 in Pennsylvania

#29,016 in US

#54,349 in the World

Philadelphia, PA, United States of America

Hemispherx Biopharma

Forward Citations = 49

3 inventors:

William A Carter (9 out of 22 patents)

David Strayer (6 out of 6 patents)

Leo Einck (1 out of 7 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com